This article examines the privacy of personal medical information in the health research context. Arguing that biomedical research in Canada has been caught up in the government's broader neoliberal policy agenda that has positioned biotechnology as a strategic driver of economic growth, the author discusses the tension between informational privacy and the need for medical information for research purposes. Consideration is given to the debate about whether privacy for medical information serves or hinders the “public good” in respect of medical research and to discussions of informed consent as an element of “fair information practices” designed to safeguard the privacy of personal information, including attempts to subvert requirements for informed consent in the medical research context.
Al-Shahi, R., & Warlow, C. (2000). Using patient-identifiable data for observational research and audit. British Medical Journal, 321, 1031-1032.
2.
Appelbaum, P.S. (2000). Protecting privacy while facilitating research . The American Journal of Psychiatry,157, 1725-1726.
3.
Association of Universities and Colleges of Canada. (2002). Framework of agreed principles on federally funded university research between the Government of Canada and the Association of Universities and Colleges of Canada. Retrieved May 2, 2007, from http://www.aucc.ca/_pdf/english/reports/2002/frame_cadre_e.pdf
4.
Bankhead, C. (2004). Privacy regulations have mixed impact on cancer research community. Journal of theNational Cancer Institute , 96, 1738-1740.
5.
Bennett, C.J., & Raab, C.D. (2006). The governance of privacy: Policy instruments in global perspective (2nd ed.). Cambridge, MA: The MIT Press.
6.
Bostrom, D., Bruce, C. , & Flanigan, S. (Eds.). (2007). AUTM Canadian licensing survey: FY2005 survey summary. Northbrook, IL: Association of University Technology Managers.
7.
Burke, M., Mooers, C., & Shields, J. (2000). Introduction: Critical perspectives on Canadian public policy. In M. Burke, C. Mooers, & J. Shields (Eds.), Restructuring and resistance: Canadian public policy in an age of global capitalism (pp. 11-23). Halifax, Nova Scotia , Canada: Fernwood Publishing .
8.
California HealthCare Foundation. (2005). National consumer health privacy survey 2005. Oakland, CA: Forrester Research.
9.
Canadian Biotechnology Advisory Committee. ( 2004). Genetic research and privacy: Advisory memorandum. Ottawa, Ontario, Canada: Government of Canada.
10.
Canadian Biotechnology Advisory Committee. ( 2006). Toward a Canadian action agenda for biotechnology: A report from the Canadian Biotechnology Advisory Committee. Ottawa, Ontario, Canada: Government of Canada.
11.
Canadian Institutes of Health Research. (2002 ). Secondary use of personal information in health research: Case studies. Ottawa, Ontario, Canada: Canadian Institutes of Health Research.
12.
Canadian Institutes of Health Research. (2003 ). The Canadian lifelong health initiative—A CIHR cross cutting initiative. Retrieved November 21, 2005, from http://www.cihr-irsc.gc.ca/e/18542.html
13.
Caulfield, T., & Ries, N.M. (2004). Consent, privacy and confidentiality in longitudinal, population health research: The Canadian legal context. Health Law Journal, 12(Suppl.), 1-65.
14.
Cheng, T., Savageau, J., DeWitt, A., & Thomas, G. (1993). Confidentiality in health care: A survey of knowledge, perceptions, and attitudes among high school students. Journal of the American Medical Association, 269(11), 1404-1408.
15.
Clayton, E.W. (1995). Panel comment: Why the use of anonymous samples for research matters. The Journal of Law, Medicine & Ethics , 23, 375-381.
16.
Davies, S.G. (1997). Re-engineering the right to privacy: How privacy has been transformed from a right to a commodity. In P. E. Agre & M. Rotenberg (Eds.), Technology and privacy: The new landscape (pp. 143-166). Cambridge, MA: The MIT Press.
17.
Etzioni, A. (1999). The limits of privacy. New York: Basic Books.
18.
Etzkowitz, H., & Webster, A. (1998). Entrepreneurial science: The second academic revolution . In H. Etzkowitz, A. Webster, & P. Healey (Eds.), Capitalizing knowledge: New intersections of industry and academia (pp. 21-46). Albany: State University of New York Press.
19.
Etzkowitz, H., Webster, A., & Healey, P. (1998). Introduction. In H. Etzkowitz, A. Webster, & P. Healey (Eds.), Capitalizing knowledge: New intersections of industry and academia (pp. 1-20). Albany: State University of New York Press.
20.
Flaherty, D.H. (1997). Controlling surveillance: Can privacy protection be made effective? In P. E. Agre & M. Rotenberg (Eds.), Technology and privacy: The new landscape (pp. 167-192). Cambridge, MA : The MIT Press.
21.
Florida, R., & Cohen, W.M. (1999). Engine or infrastructure? The university role in economic development. In L. M. Branscomb , F. Kodama, & R. Florida (Eds.), Industrializing knowledge: University-industry linkages in Japan and the United States (pp. 589-610). Cambridge, MA: The MIT Press.
22.
Gaskell, G., Bauer, M.W., & Durant, J. (1998). The representation of biotechnology: Policy, media and public perception. In J. Durant, M. W. Bauer, & G. Gaskell (Eds.), Biotechnology in the public sphere: A European sourcebook (pp. 3-12). London: Cromwell Press.
23.
Genome Canada. (n.d.). About Genome Canada . Retrieved March 14, 2007, from http://www.genomecanada.ca/xcorporate/about/index.asp
24.
Gostin, L.O., & Hodge, J.G., Jr. (2002). Personal privacy and common goods: A framework for balancing under the national health information privacy rule . Minnesota Law Review, 86, 1439-1480.
25.
Government of Canada. (2004). Biotechnology transforming society: Creating an innovative economy and a higher quality of life: Report on biotechnology (1998-2003). Ottawa, Ontario, Canada: Government of Canada.
26.
Guterman, L. (2005). Federal privacy rules may hamper medical research, study finds. Chronicle of Higher Education, 59(39), p. A18.
27.
Industry Canada. (2000). Pathways to growth: Opportunities in biotechnology . Ottawa, Ontario, Canada: Government of Canada.
28.
Ingelfinger, J.R., & Drazen, J.M. (2004). Registry research and medical privacy. The New England Journal of Medicine, 350, 1452-1453.
29.
Jessop, B. (1994). Post-fordism and the state. In A. Amin (Ed.), Post-fordism: A reader (pp. 251-279). Oxford, UK: Blackwell.
30.
Krimsky, S. (1991). Biotechnics & society: The rise of industrial genetics. New York: Praeger.
31.
Kulynych, J., & Korn, D. (2002). Use and disclosure of health information in genetic research: Weighing the impact of the new federal medical privacy rule. American Journal of Law &Medicine, 28, 309-324.
32.
Leaders' Forum Steering Committee. (2004, September 8). Strengthening the foundation of Canada's health research enterprise: A backgrounder (Leaders' Forum for Health Research in Canada) . Retrieved November 10, 2005, from http://chrc-crsc.ca/english/upload/1069/BackgrounderV7_Eng.pdf
33.
Lowrance, W. (2003). Learning from experience: Privacy and the secondary use of data in health research. Journal of Health Services Research & Policy, 8(Suppl. 1), 2-7.
34.
Lyon, D. (1988). The information society: Issues and illusions. Cambridge, UK: Polity.
35.
Macklin, R. (1992). Privacy and control of genetic information. In G. J. Annas & S. Elias (Eds.), Gene mapping: Using law and ethics as guides (pp. 157-172). New York: Oxford University Press.
36.
McCarthy, D.B., Shatin, D., Drinkard, C.R., Kleinman, J.H., & Gardner, J.S. (1999). Medical records and privacy: Empirical effects of legislation. Health Services Research, 34, 417-426.
37.
McGiffen, S.P. (2005). Biotechnology: Corporate power versus the public interest. London: Pluto.
38.
Mulligan, E.C. (2001). Confidentiality in health records: Evidence of current performance from a population survey in South Australia. Medical Journal of Australia, 174, 637-640.
39.
Peekhaus, W. (2006). Personal medical information: Privacy or personal data protection?Canadian Journal of Law & Technology , 5, 87-106.
40.
Pole, K. (1997). Privacy watchdog takes a bite at pre-pubescent big brother (allowing medical records to be used for research). Medical Post, 33(35), 8.
41.
Powell, W.W., & Owen-Smith, J. (1998). Universities and the market for intellectual property in the life sciences. Journal of Policy Analysis and Management, 17, 253-277.
42.
Powers, M. (1997). Justice and genetics: Privacy protection and the moral basis of public policy. In M. A. Rothstein (Ed.), Genetic secrets: Protecting privacy and confidentiality in the genetic era (pp. 355-368). New Haven, CT: Yale University Press.
43.
Raab, C.D. (1999). From balancing to steering: New directions for data protection. In C. J. Bennett & R. Grant (Eds.), Visions of privacy: Policy choices for the digital age (pp. 68-93). Toronto, Ontario, Canada: University of Toronto Press.
44.
Regan, P.M. (1995). Legislating privacy: Technology, social values, and public policy. Chapel Hill: University of North Carolina Press.
45.
Rule, J.B., McAdam, D., Stearns, L., & Uglow, D. (1980). The politics of privacy. New York: Mentor Books.
46.
Simitis, S. (1995). From the market to the polis: The EU directive on the protection of personal data. Iowa Law Review, 80(3), 445-469.
47.
Steeves, V. (2004, October). Will changes in data health privacy legislation kill research as we know it?Paper presented at the 2004 Annual Labelle Lectureship—Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Ontario, Canada.
48.
Tu, J.V., Willison, D.J., Silver, F.L., Fang, J., Richards, J.A., Laupacis, A., et al. (2004). Impractibility of informed consent in the registry of the Canadian stroke network. The New England Journal of Medicine, 350, 1414-1421.
49.
Tunick, M. (2001). Does privacy undermine community? Journal of ValueInquiry, 35(4), 517-534.
50.
Upshur, R.E.G., Morin, B., & Goel, V. (2001). The privacy paradox: Laying Orwell's ghost to rest. Canadian Medical Association Journal, 165, 307-310.
51.
Westin, A.F. (1967). Privacy and freedom. New York : Atheneum.
52.
Willison, D.J. (2003). Privacy and the secondary use of data for health research: Experience in Canada and suggested directions forward. Journal of Health Services Research & Policy, 8(Suppl. 1), 17-23.
53.
Willison, D.J., Keshavjee, K., Nair, K., Goldsmith, C., & Holbrook, A.M. (2003). Patients' consent preferences for research uses of information in electronic medical records: Interview and survey data. British Medical Journal, 326, 373-377.
